GlassScriptPhysician profile
Milena Jani
NPI 1447411004
$2,630.03
in general payments reported to CMS, 2019-2025
13 companies · $725 in 2025
The $725 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.32 · 2020: $123 · 2021: $14.38 · 2022: $508 · 2023: $664 · 2024: $584 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,873 · Grant: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,872.70 |
| Grant | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,503.83 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Mitraclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.76 | 2022-2024 | Jardiance |
| Cvrx, INC. | $131.88 | 2023 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $126.61 | 2024 | Assure Wcd |
| Pfizer INC. | $123.65 | 2022-2025 | |
| Boston Scientific Corporation | $100.00 | 2024 | |
| Abiomed | $76.69 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.99 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $69.68 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.84 | 2025 | |
| Baxter Healthcare | $55.78 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $19.92 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $16.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milena Jani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.